When was Clevatess developed?

When was Clevatess developed? This innovative medical device represents a significant advancement in transcatheter mitral valve repair technology, with its development timeline spanning several years of rigorous research and clinical testing.

Clevatess Development Timeline

Clevatess was developed by Edwards Lifesciences, with the initial research and development phases beginning in the early 2010s. The device received its CE Mark approval in Europe in 2020, marking a major milestone in its commercial availability. However, the journey from concept to market involved extensive preclinical studies, prototype iterations, and comprehensive clinical trials.

Clinical Trial Phases

The pivotal CLASP study, which evaluated Clevatess safety and efficacy, commenced in 2018 and provided crucial data supporting the device's regulatory approval. This multicenter clinical trial demonstrated the system's ability to effectively treat mitral regurgitation in patients who were considered high-risk or inoperable candidates for traditional surgical repair.

FDA Approval Status

While Clevatess gained European approval in 2020, the device's development for the U.S. market continued through additional clinical studies required by the FDA. The company has been working systematically through the regulatory process to bring this technology to American patients.

Innovation Behind the Development

The development of Clevatess addressed a critical unmet medical need in treating functional mitral regurgitation. Engineers and clinicians collaborated to create a transcatheter solution that could provide durable results while minimizing procedural risks for high-risk patient populations.

The device's unique design features, including its innovative leaflet repair mechanism, required years of refinement to achieve optimal clinical outcomes. This development process involved extensive computational modeling, bench testing, and animal studies before advancing to human trials.

To learn more about Clevatess clinical outcomes and its impact on patient care, explore the latest research publications and ongoing clinical studies evaluating this groundbreaking mitral valve repair technology.